<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <laws />
    <notes />
    <billNumber>2422</billNumber>
    <originChamber>House</originChamber>
    <billType>HR</billType>
    <subjects>
      <billSubjects>
        <legislativeSubjects>
          <item>
            <name>Administrative law and regulatory procedures</name>
          </item>
          <item>
            <name>Department of Health and Human Services</name>
          </item>
          <item>
            <name>Drug safety, medical device, and laboratory regulation</name>
          </item>
          <item>
            <name>Health technology, devices, supplies</name>
          </item>
          <item>
            <name>Product safety and quality</name>
          </item>
        </legislativeSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
      </billSubjects>
    </subjects>
    <titles>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <title>To amend the Federal Food, Drug, and Cosmetic Act with respect to third-party quality system assessment.</title>
        <chamberName />
        <chamberCode />
        <parentTitleType />
      </item>
      <item>
        <titleType>Display Title</titleType>
        <title>To amend the Federal Food, Drug, and Cosmetic Act with respect to third-party quality system assessment.</title>
        <chamberName />
        <chamberCode />
        <parentTitleType />
      </item>
    </titles>
    <calendarNumbers />
    <cosponsors />
    <actions>
      <actionTypeCounts>
        <billReferrals>1</billReferrals>
        <introducedInTheHouse>1</introducedInTheHouse>
        <placeholderTextForH>1</placeholderTextForH>
        <introducedInHouse>1</introducedInHouse>
      </actionTypeCounts>
      <item>
        <actionDate>2015-05-22</actionDate>
        <committee>
          <name>Health Subcommittee</name>
          <systemCode>hsif14</systemCode>
        </committee>
        <links />
        <sourceSystem>
          <name>House committee actions</name>
          <code>1</code>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionCode>H11100</actionCode>
        <committee>
          <name>Energy and Commerce Committee</name>
          <systemCode>hsif00</systemCode>
        </committee>
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <links />
        <type>IntroReferral</type>
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
        <actionDate>2015-05-19</actionDate>
      </item>
      <item>
        <actionCode>Intro-H</actionCode>
        <committee />
        <text>Introduced in House</text>
        <links />
        <type>IntroReferral</type>
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
        <actionDate>2015-05-19</actionDate>
      </item>
      <item>
        <actionCode>1000</actionCode>
        <committee />
        <text>Introduced in House</text>
        <links />
        <type>IntroReferral</type>
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
        <actionDate>2015-05-19</actionDate>
      </item>
      <actionByCounts>
        <houseOfRepresentatives>4</houseOfRepresentatives>
      </actionByCounts>
    </actions>
    <constitutionalAuthorityStatementText><![CDATA[<pre>[Congressional Record Volume 161, Number 77 (Tuesday, May 19, 2015)]From the Congressional Record Online through the Government Publishing Office [<a href='http://www.gpo.gov'>www.gpo.gov</a>]By Mr. SHIMKUS:H.R. 2422.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8, Clause 3: To regulate Commerce withforeign Nations, and among the several States, and with theIndian Tribes.[Page H3389]</pre>]]></constitutionalAuthorityStatementText>
    <cboCostEstimates />
    <version>1.0.0</version>
    <relatedBills>
      <item>
        <type>HR</type>
        <number>6</number>
        <congress>114</congress>
        <relationshipDetails>
          <item>
            <identifiedBy>CRS</identifiedBy>
            <type>Related bill</type>
          </item>
        </relationshipDetails>
        <latestAction>
          <actionDate>2015-07-13</actionDate>
          <text>Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
        </latestAction>
        <latestTitle>21st Century Cures Act</latestTitle>
      </item>
      <item>
        <type>S</type>
        <number>2187</number>
        <congress>114</congress>
        <relationshipDetails>
          <item>
            <identifiedBy>CRS</identifiedBy>
            <type>Related bill</type>
          </item>
        </relationshipDetails>
        <latestAction>
          <actionDate>2015-10-21</actionDate>
          <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
        </latestAction>
        <latestTitle>FDA Regulatory Efficiency Act</latestTitle>
      </item>
    </relatedBills>
    <recordedVotes />
    <summaries>
      <billSummaries>
        <item>
          <versionCode>00</versionCode>
          <text><![CDATA[<p>This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to establish a third-party quality system assessment program to accredit persons to assess whether a medical device manufacturer's quality system can ensure the safety and effectiveness of an approved medical device after certain changes, including changes in manufacturing or changes to enhance device safety.</p> <p>Device manufacturers are allowed to make changes to a device without submitting to the FDA the 30-day notice required for manufacturing changes or a premarket approval supplement if their quality system has been certified by an accredited person.</p> <p>An accredited person who assesses a device manufacturer's quality system must submit a summary of their assessment and, as appropriate, a certification to the FDA within 30 days of the assessment. An assessment summary and certification is deemed accepted by the FDA 30 days after submission unless the FDA determines that additional information is needed to support certification, the assessment or certification is unwarranted, or an action other than acceptance of the certification is otherwise justified.</p> <p>Periodic reports by device manufacturers must describe any changes made to a device without submission of the 30-day notice or the premarket approval supplement. </p> <p>Certifications accepted by the FDA remain in effect for two years.</p> The FDA must report on this quality system assessment program no later than January 31, 2022. The program is terminated at the end of FY2022.]]></text>
          <actionDesc>Introduced in House</actionDesc>
          <name>Introduced in House</name>
          <updateDate>2015-05-19T04:00:00Z</updateDate>
          <lastSummaryUpdateDate>2015-11-16T16:45:11Z</lastSummaryUpdateDate>
          <actionDate>2015-05-19</actionDate>
        </item>
      </billSummaries>
    </summaries>
    <committees>
      <billCommittees>
        <item>
          <activities>
            <item>
              <name>Referred to</name>
              <date>2015-05-19T14:06:25Z</date>
            </item>
          </activities>
          <chamber>House</chamber>
          <subcommittees>
            <item>
              <systemCode>hsif14</systemCode>
              <name>Health Subcommittee</name>
              <activities>
                <item>
                  <name>Referred to</name>
                  <date>2015-05-22T15:09:27Z</date>
                </item>
              </activities>
            </item>
          </subcommittees>
          <name>Energy and Commerce Committee</name>
          <type>Standing</type>
          <systemCode>hsif00</systemCode>
        </item>
      </billCommittees>
    </committees>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <title>To amend the Federal Food, Drug, and Cosmetic Act with respect to third-party quality system assessment.</title>
    <introducedDate>2015-05-19</introducedDate>
    <createDate>2015-05-20T08:46:21Z</createDate>
    <latestAction>
      <actionDate>2015-05-22</actionDate>
      <text>Referred to the Subcommittee on Health.</text>
      <links />
    </latestAction>
    <amendments />
    <sponsors>
      <item>
        <party>R</party>
        <middleName>M.</middleName>
        <lastName>SHIMKUS</lastName>
        <identifiers>
          <bioguideId>S000364</bioguideId>
          <lisID>1527</lisID>
          <gpoId>7939</gpoId>
        </identifiers>
        <state>IL</state>
        <byRequestType />
        <fullName>Rep. Shimkus, John [R-IL-15]</fullName>
        <bioguideId>S000364</bioguideId>
        <firstName>JOHN</firstName>
        <district>15</district>
      </item>
    </sponsors>
    <congress>114</congress>
    <updateDate>2018-11-21T21:23:12Z</updateDate>
    <committeeReports />
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

